Skip to main content
. 2019 Sep 7;10(23):5705–5713. doi: 10.7150/jca.29162

Table 1.

Characteristics of patients with gastric ASC and AC

Characteristics ASC AC p value
Number 93(0.2%) 41794(99.8%)
Age (years) 68.72±12.42 70.85±15.19 0.078
Gender
Female 35(37.6%) 17194(41.1%) 0.528
Male 58(62.4%) 24600(58.9%)
Ethnicity
White 56(60.2%) 26146(62.6%) 0.078
Black 25(26.9%) 7280(17.4%)
Other 12(12.9%) 8262(19.8%)
Unknown 0 106(0.3%)
Marital status
Single 14(15.1%) 5222(12.5%) 0.128
Married 58(62.4%) 22164(53.0%)
Separated/divorced 6(6.5%) 3402(8.1%)
Widowed 10(10.8%) 8837(21.1%)
Other/unknown 5(5.4%) 2169(5.2%)
Primary site
Fundus 9(9.7%) 2403(5.7%) 0.155
Body 8(8.6%) 5244(12.5%)
Antrum 26(28.0%) 12233(29.3%)
Pylorus 7(7.5%) 1871(4.5%)
Lesser curvature, NOS 14(15.1%) 4884(11.7%)
Greater curvature, NOS 4(4.3%) 2197(5.3%)
Overlapping lesion 13(14.0%) 4304(10.3%)
Stomach, NOS 12(12.9%) 8658(20.7%)
Pathological differentiation
Well 1(1.1%) 1924(4.6%) 0.002
Moderate 11(11.8%) 11031(26.4%)
Poor 69(74.2%) 21885(52.4%)
Undifferentiated 2(2.2%) 637(1.5%)
Unknown 10(10.8%) 6317(15.1%)
Summary stage
In situ 0 555(1.3%) 0.002
Localized 9(9.7%) 10009(23.9%)
Regional 37(39.8%) 12785(30.6%)
Distant 43(46.2%) 14026(33.6%)
Unstaged 4(4.3%) 4419(10.6%)
T stage
T0/Tis/T1 7(7.5%) 7740(18.5%) 0.036
T2 19(20.4%) 8132(19.5%)
T3 9(9.7%) 3428(8.2%)
T4 14(15.1%) 3762(9.0%)
Unknown 44(47.3%) 18732(44.8%)
Lymph node metastasis
Yes 32(34.4%) 11747(28.1%) 0.259
No 23(24.7%) 13233(31.7%)
Unknown 38(40.9%) 16814(40.2%)
Distant metastasis
Yes 31(33.3%) 9970(23.9%) 0.026
No 28(30.1%) 17871(42.8%)
Unknown 34(36.6%) 13953(33.4%)
Surgery
Yes 57(61.3%) 21113(50.5%) 0.080
No 36(38.7%) 20130(48.2%)
Unknown 0 551(1.3%)
Radiation
Yes 19(20.4%) 6880(16.5%) 0.326
No/unknown 74(79.6%) 34914(83.5%)
Chemotherapy
Yes 41(44.1%) 14218(34.0%) 0.048
No/unknown 52(55.9%) 27576(66.0%)

ASC: adenosquamous carcinoma; AC: adenocarcinoma. The significant p values are in bold.